Literature DB >> 6833622

Amrinone--promising innovation for treatment of the failing heart.

R Hayward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6833622     DOI： 10.1007/bf01693697

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].

Authors:  A A Alousi; A E Farah; G Y Lesher; C J Opalka
Journal:  Circ Res       Date:  1979-11       Impact factor: 17.367

Review 2.  Biochemical "defect" in the hypertrophied and failing heart: deleterious or compensatory?

Authors:  A M Katz
Journal:  Circulation       Date:  1973-05       Impact factor: 29.690

3.  Haemodynamic effects of prenalterol in patients with coronary heart disease.

Authors:  I Hutton; R G Murray; R N Boyes; A P Rae; W S Hillis
Journal:  Br Heart J       Date:  1980-02

4.  Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.

Authors:  T H LeJemtel; E C Keung; W J Schwartz; C S Maskin; M A Greenberg; R S Davis; R Forman; H S Ribner; E H Sonnenblick
Journal:  Trans Assoc Am Physicians       Date:  1979

5.  Effects of amrinone on experimental acute myocardial ischaemic injury.

Authors:  R E Rude; R A Kloner; P R Maroko; S Khuri; S Karaffa; L W DeBoer; E Braunwald
Journal:  Cardiovasc Res       Date:  1980-07       Impact factor: 10.787

6.  Left ventricular dynamics during long-term digoxin treatment in patients with stable coronary artery disease.

Authors:  J H Kleiman; N B Ingels; G Daughters; E B Stinson; E L Alderman; R H Goldman
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

7.  Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.

Authors:  T H LeJemtel; E Keung; H S Ribner; R Davis; J Wexler; J D Blaufox; E H Sonnenblick
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

8.  Amrinone and exercise performance in patients with chronic heart failure.

Authors:  K T Weber; V Andrews; J S Janicki; J R Wilson; A P Fishman
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

9.  Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.

Authors:  R Ariniego; F Waagstein; B Mombay; A Hjalmarson
Journal:  Br Heart J       Date:  1979-08

10.  Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.

Authors:  N A Klein; S J Siskind; W H Frishman; E H Sonnenblick; T H LeJemtel
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.